CF and non-CF bronchiectasis

Integration of multi-omics datasets enables molecular classification of COPD
Chuan-Xing Li, Craig E. Wheelock, C. Magnus Sköld, Åsa M. Wheelock

European Respiratory Journal May 2018, 51 (5) 1701930; DOI: 10.1183/13993003.01930-2017
Elastase activity on sputum neutrophils correlates with severity of lung disease in cystic fibrosis
A. Susanne Dittrich, Iris Kühbandner, Stefanie Gehrig, Verena Rickert-Zacharias, Matthew Twigg, Sabine Wege, Clifford C. Taggart, Felix Herth, Carsten Schultz, Marcus A. Mall

European Respiratory Journal Mar 2018, 51 (3) 1701910; DOI: 10.1183/13993003.01910-2017
Airway infection, systemic inflammation and lung clearance index in children and adults with cystic fibrosis
Katherine O'Neill, Judy M. Bradley, Alastair Reid, Damian G. Downey, Jacqueline Rendall, John McCaughan, John E. Moore, Michael M. Tunney, J. Stuart Elborn

European Respiratory Journal Feb 2018, 51 (2) 1701704; DOI: 10.1183/13993003.01704-2017
Pseudomonas aeruginosa infection and exacerbations in bronchiectasis: more questions than answers
Miguel Angel Martinez-García

European Respiratory Journal Feb 2018, 51 (2) 1702497; DOI: 10.1183/13993003.02497-2017
RESPIRE 1: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Anthony De Soyza, Timothy Aksamit, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson

European Respiratory Journal Jan 2018, 51 (1) 1702052; DOI: 10.1183/13993003.02052-2017
RESPIRE: breathing new life into bronchiectasis
Sanjay H. Chotirmall, James D. Chalmers

European Respiratory Journal Jan 2018, 51 (1) 1702444; DOI: 10.1183/13993003.02444-2017
RESPIRE 2: a phase III placebo-controlled randomised trial of ciprofloxacin dry powder for inhalation in non-cystic fibrosis bronchiectasis
Timothy Aksamit, Anthony De Soyza, Tiemo-Joerg Bandel, Margarita Criollo, J. Stuart Elborn, Elisabeth Operschall, Eva Polverino, Katrin Roth, Kevin L. Winthrop, Robert Wilson

European Respiratory Journal Jan 2018, 51 (1) 1702053; DOI: 10.1183/13993003.02053-2017
Cross-infection risk in patients with bronchiectasis: a position statement from the European Bronchiectasis Network (EMBARC), EMBARC/ELF patient advisory group and European Reference Network (ERN-Lung) Bronchiectasis Network
James D. Chalmers, Felix C. Ringshausen, Bridget Harris, J. Stuart Elborn, Annette Posthumus, Charles S. Haworth, Nicola Pilkington, Eva Polverino, Thomas Ruddy, Stefano Aliberti, Pieter C. Goeminne, Craig Winstanley, Anthony De Soyza

European Respiratory Journal Jan 2018, 51 (1) 1701937; DOI: 10.1183/13993003.01937-2017
Long-term benefits of airway clearance in bronchiectasis: a randomised placebo-controlled trial
Gerard Muñoz, Javier de Gracia, Maria Buxó, Antonio Alvarez, Montserrat Vendrell

European Respiratory Journal Jan 2018, 51 (1) 1701926; DOI: 10.1183/13993003.01926-2017
ELTGOL airway clearance in bronchiectasis: laying the bricks of evidence
Conroy Wong, Cameron Sullivan, Lata Jayaram

European Respiratory Journal Jan 2018, 51 (1) 1702232; DOI: 10.1183/13993003.02232-2017

Main menu

User menu

Search

CF and non-CF bronchiectasis

Pages

Contact us